A paradigm shift in rapid molecular testing. On-site. Cloud-Connected. Data-driven.
Alveo's rapid detection platform provides real-time data and empowers more industries to Know Sooner, Act Faster™.
Portable & Rechargeable
Rugged analzyer can test for pathogens anywhere.
Cloud Connected
Analyzer + companion mobile app deliver accurate, fast results with automated data upload to the cloud.
Outstanding Accuracy
Single use disposable test cartridges with spatial multiplexing offer flexibility & power to detect critical targets in a single test.
Traceable
Field results are aggregated and displayed for super users on their PC or mobile device via our AWS support cloud infrastructure.
Secure
Bluetooth connectivity with Level 3 encryption.
Control
Full individual or institutional control of access to data.
IntelliSense™ powers our go-anywhere, bluetooth-enabled Analyzer and companion mobile app.
The Alveo Analyzer makes rapid, accurate, portable molecular testing possible.
.avif)
With patented electrical impedance sensing technology that delivers accurate pathogen detection in minutes.
Sample and buffer fill the cartridge well that and resuspend the dried reagents - the test immediately begins.
If the target is present in the sample, the reagents in the cartridge will start to amplify it, generating a change in the well chemistry.
Electrical signals are sent through the well and the level of signal impedance due to the amplification determines if the target is present.
Alveo Vista™ provides real-time access to secure, traceable, actionable data.
- GeoTrace™ capabilities provide up-to-date information on problematic areas.
- Time-stamped, geo-tagged results are stored in a secure portal.
- Data-driven testing capabilities provide public health officials a real-time view of outbreaks in their area.
- Customizable reporting capabilities meet an organization’s distinct needs.
- Role-based user access control enables varying levels of access within an organization.
- 2-factor authentication and encrypted data storage support data security and access control.
The creation of a decentralized testing ecosystem that respects and expands process control by disease management authorities, combined with molecular biology levels of accuracy, could lead a paradigm shift in the way notifiable disease challenges are controlled. With the Alveo platform, test results are time and geotagged, to track, trace and tag to support ongoing widespread monitoring programs. This has never been possible before and will be a powerful tool to fight the spread of this pathogen and help ensure food security for millions of people around the globe.
President, x-OvO
The Alveo platform finally solves a problem that has been unaddressed for far too long by decentralizing testing but centralizing reporting. I've dedicated my career to researching emerging infectious diseases and the tools required to combat them. This disruptive technology has the potential to dramatically shift the way we are able to detect and respond to viruses globally, which is key to preventing the next pandemic.
Program Director, Global Virus Network
Faculty, Johns Hopkins Bloomberg School of Public Health
Together, the Alveo Analyzer and mobile app offer a simple, seamless workflow from sample to actionable results in under an hour. No specialized training required.
Current molecular testing must be performed in a qualified laboratory environment. Samples must be transported to a lab for processing — which requires costly, specialized resources and can put potentially critical hours or days between testing and results analysis and action.
See what Alveo can do for your industry.
be.well™ is where molecular diagnostics meets healthcare needs for the 21st century.
Alveo partnerships create access to rapid, early detection across academic research, industry sectors, and pathogen types.
Enabling better outcomes across more industries through advanced molecular detection.